The canine telomerase catalytic subunit (dogTERT): Characterisation of the gene promoter and identification of proximal core sequences necessary for specific transcriptional activity in canine telomerase positive cell lines

Gene

Volumn 358, Issue 1-2, 2005, Pages 111-120

  Long, S ^a   Argyle, D J ^b   Gault, E A ^a   Campbell, S ^a,c   Nasir, L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Dog; Telomerase reverse transcriptase; Transcriptional binding factors

Indexed keywords

PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CANCER PATIENT; CATALYSIS; CELL LINE; CODON; CONTROLLED STUDY; DNA FLANKING REGION; DOG; E BOX ELEMENT; FIBROBLAST; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; SEQUENCE ANALYSIS; TATA BOX;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CODON, INITIATOR; DNA-BINDING PROTEINS; DOGS; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; RESPONSE ELEMENTS; SPECIES SPECIFICITY; TATA BOX; TELOMERASE; TELOMERE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

ANIMALIA; CANIS FAMILIARIS;

EID: 24944564306     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2005.05.030     Document Type: Article

References (41)

1. A.A. Avilion, M.A. Piatyszek, J. Gupta, J.W. Shay, S. Bacchetti, and C.W. Greider Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues Cancer Res. 56 1996 645 650
2. A.E. Bilsland Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase Oncogene 22 2003 370 380
3. M.A. Blasco Opinion: telomerase beyond telomeres Nat. Rev., Cancer 2 2002 627 633
4. D. Broccoli, J.W. Young, and T. de Lange Telomerase activity in normal and malignant hematopoietic cells Proc. Natl. Acad. Sci. U. S. A. 92 1995 9082 9086
5. Y.S. Cong, J. Wen, and S. Bacchetti The human telomerase catalytic subunit hTERT: organisation of the gene and characterization of the promoter Hum. Mol. Genet. 8 1999 137 142
6. C.M. Counter, J. Gupta, C.B. Harley, B. Leber, and S. Bacchetti Telomerase activity in normal leukocytes and in hematologic malignancies Blood 85 1995 2315 2320
7. J.M. Dobson, S. Samuel, H. Milstein, K. Rogers, and J.L. Wood Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs J. Small Anim. Pract. 43 2002 240 246
8. A.L. Ducrest Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity Cancer Res. 61 2001 7594 7602
9. P.A. Fradiani, F. Ascenzioni, M. Lavitrano, and P. Donini Telomeres and telomerase activity in pig tissues Biochimie 86 2004 7 12
10. K. Fujimoto Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT Nucleic Acids Res. 28 2000 2557 2562
11. C.B. Harley Telomere loss: mitotic clock or genetic time bomb? Mutat. Res. 256 1991 271 282
12. C.B. Harley, A.B. Futcher, and C.W. Greider Telomeres shorten during ageing of human fibroblasts Nature 345 1990 458 460
13. N.D. Hastie, M. Dempster, M.G. Dunlop, A.M. Thompson, D.K. Green, and R.C. Allshire Telomere reduction in human colorectal carcinoma and with ageing Nature 346 1990 866 868
14. I. Horikawa, P.L. Cable, C.A. Afshari, and J.C. Barrett Cloning and characterisation of the promoter region of human telomerase reverse transcriptase gene Cancer Res. 59 1999 826 830
15. S. Koga A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter Hum. Gene Ther. 11 2000 1397 1406
16. S. Koga FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo Anticancer Res. 21 2001 1937 1943
17. T. Komata A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter Int. J. Oncol. 19 2001 1015 1020
18. S. Kyo Estrogen activates telomerase Cancer Res. 59 1999 5917 5921
19. S. Kyo Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT) Nucleic Acids Res. 28 2000 669 677
20. C.V. Lohr, J.P. Teifke, K. Failing, and E. Weiss Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA Vet. Pathol. 34 1997 212 221
21. K. Masutomi Telomerase maintains telomere structure in normal human cells Cell 114 2003 241 253
22. M. Meyerson hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization Cell 90 1997 785 795
23. S. Misiti Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells Mol. Cell. Biol. 20 2000 3764 3771
24. T.M. Nakamura Telomerase catalytic subunit homologs from fission yeast and human Science 277 1997 955 959
25. L. Nasir, P. Devlin, T. Mckevitt, G. Rutteman, and D.J. Argyle Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology Neoplasia 3 2001 351 359
26. L. Nasir Isolation and expression of the reverse transcriptase component of the Canis familiaris telomerase ribonucleoprotein (dogTERT) Gene 336 2004 105 113
27. S. Oh, Y. Song, J. Yim, and T.K. Kim The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene J. Biol. Chem. 274 1999 37473 37478
28. S. Oh, Y.H. Song, J. Yim, and T.K. Kim Identification of Mad as a repressor of the human telomerase (hTERT) gene Oncogene 19 2000 1485 1490
29. J.A. Plumb Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954 Oncogene 20 2001 7797 7803
30. J.C. Poole, L.G. Andrews, and T.O. Tollefsbol Activity, function and gene regulation of the catalytic subunit of telomerase (hTERT) Gene 269 2001 1 12
31. K.R. Prowse, and C.W. Greider Developmental and tissue-specific regulation of mouse telomerase and telomere length Proc. Natl. Acad. Sci. U. S. A. 92 1995 4818 4822
32. S. Renaud, F.T. Bosman, and M.S. Berger Implication of the exon region in the regulation of the human telomerase reverse transcriptase gene promoter Biochem. Biophys. Res. Commun. 300 2003 47 54
33. I. Russo, A.R. Silver, A.P. Cuthbert, D.K. Griffin, D.A. Trott, and R.F. Newbold A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization Oncogene 17 1998 3417 3426
34. G.G. Sharma hTERT associates with human telomeres and enhances genomic stability and DNA repair Oncogene 22 2003 131 146
35. J.W. Shay, and S. Bacchetti A survey of telomerase activity in human cancer Eur. J. Cancer 33 1997 787 791
36. M. Takakura Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells Cancer Res. 59 1999 551 557
37. C. Weiss, and D. Bohmann Deregulated repression of c-Jun provides a potential link to its role intumorigenesis Cell Cycle 3 2004 111 113
38. N.P. Weng, B.L. Levine, C.H. June, and R.J. Hodes Regulated expression of telomerase activity in human T lymphocyte development and activation J. Exp. Med. 183 1996 2471 2479
39. M. Wick, D. Zubov, and G. Hagen Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT) Gene 232 1999 97 106
40. W.E. Wright, M.A. Piatyszek, W.E. Rainey, W. Byrd, and J.W. Shay Telomerase activity in human germline and embryonic tissues and cells Dev. Genet. 18 1996 173 179
41. D. Xu Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells Proc. Natl. Acad. Sci. U. S. A. 98 2001 3826 3831